We Believe in a Better Quality of Life


What is hereditary angioedema?

Hereditary angioedema (Quincke’s Disease) is a rare but serious immune system condition that is passed down through families. It causes swelling, particularly of the face and airways, and abdominal cramping.

Hereditary angioedema (HAE) is caused by low levels or improper function of a protein called C1 inhibitor. This problem affects the blood vessels. People with hereditary angioedema can develop rapid swelling of the hands, feet, limbs, face, intestinal tract, larynx (voicebox), or trachea (windpipe).

Dental procedures, sickness (including colds and the flu), and surgery may trigger the onset of hereditary angioedema.

What to expect?

Because HAE is genetic in nature, treatment plans are unique to a patient’s individual symptoms. Treatment side effects, if any, may vary with each individual patient depending on the treatment type.

How is hereditary angioedema treated?

There is a wide range of treatment options used for treating HAE including antihistamines (of which have limited benefit), epinephrine (when life-threatening reactions occur), a C1 inhibitor concentrate, peptidomimetic drugs, certain protein and amino acid inhibitors, and androgen medications.

Helicobacter pylori, a type of bacteria found in the stomach, can trigger abdominal attacks. Antibiotics to treat h. pylori will decrease abdominal attacks. Once an attack occurs, treatment includes pain relief and fluids given through a vein by an intravenous (IV) line.

How can a specialty pharmacy help?

Kroger Specialty Pharmacy sets a clear path to caring, compassionate therapy management and support.

Kroger Specialty Pharmacy is able to provide patients, providers and partners with the necessary coordination of care vital to achieving successful treatment outcomes. By utilizing our expert patient care team comprised of Doctors of Pharmacy, registered pharmacists and nurses, reimbursement specialists and dedicated Patient Care Coordinators (PCCs), we are able to offer each and every patient and partner with high-quality, personalized care, ongoing patient evaluation and clinical support including frequent patient follow-up and continual education about their HAE treatment.